NCT05123001View on ClinicalTrials.gov

Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events

CompletedOBSERVATIONAL

Enrollment

11

Participants

Timeline

Start Date

July 15, 2021

Primary Completion Date

July 7, 2022

Study Completion Date

July 7, 2022

Conditions

Hodgkin LymphomaNon Hodgkin LymphomaLeukemiaMultiple Myeloma

Trial Locations (1)

94305

Stanford University, Palo Alto

All Listed Sponsors

lead

Stanford University

OTHER